| Material Didático | ||
Neuroimaging in the characterization of the epileptic syndromes
Fernando Cendes
Abstract
Thin coronal MRI slices,
perpendicular to the axis of the hippocampus, give the best images for determining
hippocampal sclerosis (HS) and other subtle
pathologies and for ascertaining anatomical detail. MRI features of HS,
detectable by visual inspection of the images, are: (i)
hippocampal smallness (atrophy) which is the most
specific and reliable feature, (ii) increased T-2 signal which in isolation may
be insufficient to diagnose HS; (iii) loss of internal structure. There may
also be asymmetry of the horns of the lateral ventricles, which is variable and
may lead to false lateralisation, and atrophy of the anterior temporal lobe,
which is non-specific. Most patients with HS undergoing presurgical
evaluation have one hippocampus which is clearly smaller than the other and
which has increased T-2 signal, along with a normal appearing contralateral hippocampus, so that volume measurement is
not necessary for clinical purposes. The
visual binary paradigm breaks down in the presence of symmetric bilateral
atrophy or mild unilateral disease. In
these cases volumetric MR analysis of the hippocampus is very sensitive and
specific for identifying HS. MRI measurements of hippocampi
are a surrogate for histopathological methods of
assessing the presence and severity of neuronal loss. This may give useful prognostic information for postoperative seizure control. Surgical treatment of unilateral HS should
give >90% excellent outcome.
Comparisons with EEG localization and surgical outcome have shown the
potential clinical utility of proton magnetic resonance spectros-copy
(MRS) in the localization of epileptogenic areas.
Proton MRS studies have shown that a reduced signal of
the neuronal marker N-acetylaspartate (NAA) can
reliably localize and lateralize epileptic foci in patients with partial
epilepsies, particularly temporal lobe epilepsy (TLE). In addition, relative
NAA signal may normalize after successful surgery for TLE.
Thin coronal magnetic
resonance imaging (MRI) slices, perpendicular to the axis of the hippocampus,
give the best images for determining hippocampal sclerosis (HS) and other
subtle pathologies and for ascertaining anatomical detail. MRI features of HS,
detectable by visual inspection of the images, are: (i)
hippocampal smallness (atrophy) which is the most specific and reliable
feature, (ii) increased T-2 signal which in isolation may be insufficient to
diagnose HS; (iii) loss of internal structure.
There may also be asymmetry
of the horns of the lateral ventricles, which is variable and may lead to false
lateralisation, and atrophy of the anterior temporal lobe, which is
non-specific. T-2 mapping is an
objective method for measuring abnormal T-2 signal, which may be difficult to
detect visually.
Most patients with HS
undergoing presurgical evaluation have one hippocampus which is clearly smaller
than the other on visual inspection, and which has increased T-2 signal, along
with a normal appearing contralateral hippocampus, so that volume measurement
is not necessary for clinical purposes.
The visual binary paradigm breaks down in the presence of symmetric
bilateral atrophy or mild unilateral disease.
In these cases volumetric MR analysis of the hippocampus and the amygdala are very sensitive and specific for identifying
HS. MRI measurements of hippocampal volumes are a surrogate for histopathological methods of assessing the presence and
severity of neuronal loss in each hippocampus allowing each to be classed as
normal or abnormal. This may give useful
prognostic information concerning postoperative seizure control. Surgical treatment of strictly unilateral HS
should give >90% excellent outcome (Engel et al. 1997; Engel, Jr. 1999; Cascino et al. 1996; Cendes et al. 2000; Arruda et al. 1996; Engel et al. 1997).
Comparisons with EEG localization and surgical outcome have shown the
potential clinical utility of proton magnetic resonance spectroscopy (MRS) in
the localization of epileptogenic areas.
MRS provides chemical information from metabolites that are present in
tissues at much lower concentration than water. A number of proton MRS studies
have shown that a reduced signal intensity of the neuronal marker N-acetyl aspartate (NAA) can reliably localize and lateralize
epileptic foci in patients with partial epilepsies, particularly temporal lobe
epilepsy (TLE). In addition, relative NAA concentration may normalize after
successful surgery for TLE. NAA may be a dynamic marker of epileptic activity,
and not simply reflect neuronal number. The MRS findings may have prognostic
value as well. Proton
magnetic resonance spectroscopy (MRS) lateralises most cases of temporal lobe
epilepsy with normal MRI and detects bilateral abnormalities more often than
does volumetric MRI although the greater sensitivity of MRS is not invariable.
Partial epilepsy arising from a part
of the brain other than the temporal lobe (extra-temporal epilepsy) comprises
about 1/3 of refractory partial epilepsies. The number of surgical procedures
performed in this group is far less and the outcome much less satisfactory than
in patients with TLE because of the: (i) difficulty in distinguishing the clinical manifestations
from those of TLE, (ii) failure to
precisely localize the seizures, even with prolonged EEG monitoring in 40 to
50% of the patients, and (iii)
failure to identify a structural lesion by conventional MRI in ~40% of patients
(Williamson et al. 1993; Williamson & Spencer, 1986; Quesney
et al. 1995).
In patients with extra-temporal
epilepsies without identifiable structural lesions, intensive EEG monitoring
with intracranially implanted electrodes is
considered necessary in most instances (Williamson et al. 1993; Engel, Jr.
& Ojemann, 1993). These invasive diagnostic
studies must be focused on a particular region of the brain and cannot be used
as a screening test. Thus, this procedure is only performed when the results of
noninvasive studies suggest a well-defined target (Engel, Jr. & Ojemann, 1993; Olivier et al. 1987) and the presence of a resectable epileptogenic region (Engel, Jr. & Ojemann, 1993; Olivier et al. 1987; Gumnit,
1991). Mapping of an epileptogenic region with implanted electrodes is
technically difficult. The risk of
complications is comparable to the risk of the epilepsy surgery itself, and the
cost (including the operative procedure and prolonged hospitalization for
monitoring) is considerable.
We recently studied 100 consecutive patients followed in our epilepsy
clinic with partial epilepsy who underwent MRI investigation (Cendes et al, 2001). The MRI protocol included
6mm sagital T1-weighted, 3-
References
Arruda,
F., Cendes, F., Andermann, F., Dubeau, F., Villemure, J.G., Jones-Gotman,
M., Poulin, N., Arnold, D.A., & Olivier, A.
(1996): Mesial atrophy and outcome after amygdalohippocampectomy
or temporal lobe removal. Ann Neurol 40, 446-450.
Cascino,
G.D., Trenerry, M.R., So, E.L., Sharbrough,
F.W., Shin, C., Lagerlund, T.D., Zupanc,
M.L., & Jack, C.R. (1996): Routine EEG and temporal lobe epilepsy -
relation to long-term EEG monitoring, quantitative MRI, and operative outcome. Epilepsia 37, 651-656.
Cendes, F., Li, L.M., Watson, C., Andermann, F., Dubeau, F., & Arnold, D.L. (2000): Is ictal recording
mandatory in temporal lobe epilepsy? Not when the interictal
electroencephalogram and hippocampal atrophy coincide. Arch Neurol 57, 497-500.
Cendes F, Ghizoni E, Santos SLM,
Li LM, Guerreiro CAM. Dynamic assessment of high
resolution MRI with multiplanar reconstruction
increases the yeld of lesion detection in patients
with partial epilepsy. Neurology
2001; 56(Suppl 3): A388.
Engel, J., Jr. (1999): When is imaging enough? Epileptic disorders 1, 249-253.
Engel, J., Jr., & Ojemann,
G.A. (1993): The Next Step. In: Surgical
Treatment of the Epilepsies, J. Engel, Jr. (Ed.), pp.
319-329. New York: Raven Press.
Engel, J.J., Cascino, G.D.,
& Shields, W.D. (1997): Surgically remediable syndromes. In: Epilepsy: A comprehensive textbook, J.
Engel, Jr. & T.A. Peddley (Eds.), pp. 1687-1696.
Philadelphia: Lippincott-Raven.
Gumnit,
R.J. (1991): Cost, accessibility, and quality-of-life issues in surgery for
epilepsy. In: Epilepsy surgery, H. Luders (Ed.), pp. 47-49. New York: Raven Press.
Olivier, A., Marchand, E.,
Peters, T., & Tyler, J. (1987): Depth electrode implantation at the
Montreal Neurological Institute and Hospital. In: Surgical treatment of the epilepsies, J. Engel, Jr. (Ed.), pp. 595-601.
New York: Raven Press.
Quesney,
L.F., Cendes, F., Olivier, A., Dubeau, F., &
Andermann, F. (1995): Intracranial electroencephalographic investigation in
frontal lobe epilepsy. In: Epilepsy and
the functional anatomy of the frontal lobe, H.H. Jasper, S. Riggio, & P.D. Goldman-Rakic
(Eds.), pp. 243-260. N. York: Raven Press.
Williamson, P., & Spencer, S.S. (1986): Clinical and
EEG features of complex partial seizures of extratemporal origin. Epilepsia 27 (suppl), 46-63.
Williamson, P.D., Van Ness, P.C., Wieser,
H., & Quesney, L.F. (1993): Surgically remediable
extratemporal syndromes. In: Surgical
Treatment of the Epilepsies, J. Engel, Jr. (Ed.), pp.
65-76. New York: Raven Press.